Vitrea CT Brain Perfusion

by Vital Images (a Canon Medical Systems Group Company)  · Based in United States →Advanced Visualization for Enhanced Diagnostic Confidence and Workflow Efficiency
Emergency Medicine Neurology Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

Vitrea CT Brain Perfusion is an advanced application within the comprehensive Vitrea Advanced Visualization suite, developed by Vital Images, now a Canon Medical Systems Group Company. This multimodality, vendor-agnostic platform provides full-powered clinical applications for 2D, 3D, and 4D advanced visualization and analysis. It is designed to standardize and consolidate radiology IT footprints, offering a scalable enterprise solution accessible anywhere and anytime through a thin-client deployment.

Specifically, Vitrea CT Brain Perfusion aids in assessing the whole brain and evaluating perfusion deficits by displaying 4D-DSA (digital subtraction angiography) views of blood flow in the vessels and 3D perfusion maps. It supports physicians in visualizing apparent blood perfusion in brain tissue affected by acute stroke. The tool offers a streamlined workflow with automatic curve-fitting, midline correction, motion correction, and region of interest templating. It automatically calculates quantitative brain perfusion results, including Regional Cerebral Blood Volume (rCBV), Mean Transit Time (MTT), Regional Cerebral Blood Flow (rCBF), Time-to-Peak (TTP), and Delay of tissue response curve.

The system also incorporates Bayesian processing, which excels at processing low signal-to-noise ratio (SNR) images, providing clarity on parametric images used to compute summary maps. A single-view Summary Map facilitates easy communication of perfusion results. Furthermore, Vitrea Advanced Visualization includes Global Illumination, a revolutionary 3D/4D rendering technique that provides a more photorealistic view of human anatomy, enhancing collaboration and patient communication.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • 2D, 3D, and 4D advanced visualization and analysis
  • Multimodality and vendor-agnostic platform
  • Scalable enterprise deployment options (Workstation, Extend, Enterprise)
  • Accessible anywhere & anytime via thin-client solution
  • Automatic calculation of quantitative brain perfusion results (rCBV, MTT, rCBF, TTP, Delay of tissue response curve)
  • Single-view Summary Map for communicating perfusion results
  • 4D cine of DSA view for visualizing contrast flow through vessels
  • Streamlined workflow with automatic curve-fitting, midline correction, motion correction, and ROI templating
  • Bayesian processing for improved clarity in low signal-to-noise ratio images
  • Global Illumination for photorealistic 3D/4D rendering

Use Cases

  • Assessing whole brain perfusion and evaluating perfusion deficits
  • Visualizing apparent blood perfusion in brain tissue affected by acute stroke
  • Identifying ischemic penumbra (dying brain tissue) for treatment decisions
  • Supporting endovascular therapy decisions in acute ischemic stroke
  • Pre-procedural and pre-operative planning
  • Enhancing diagnostic confidence and data access in neuroimaging

What Physicians Need to Know

Stroke Detection Speed
Vitrea's Bayesian CTP algorithm processes perfusion data in approximately 186.2 u00b1 5.3 seconds (around 3 minutes), enabling rapid assessment of infarct and penumbra volumes. When integrated with Canon's Automation Platform, it supports swift analysis and categorization of brain images for confident and fast clinical decision-making in stroke management.
Brain MRI/CT Analysis
Vitrea CT Brain Perfusion is a noninvasive post-processing application for dynamic CT data, calculating cerebral blood flow (CBF), cerebral blood volume (CBV), mean transit time (MTT), time-to-peak (TTP), and delay time. It visualizes apparent blood perfusion in brain tissue affected by acute stroke and quantifies infarct and penumbra to aid in treatment eligibility. The system also offers 4D-DSA views of blood flow.
Large Vessel Occlusion Detection
While Vitrea CT Brain Perfusion focuses on perfusion, it is part of Canon's broader stroke solution. Canon's Automation Platform, which integrates with Vitrea, includes a CINAu00ae LVO application that uses deep learning to identify large vessel occlusions (LVOs) in CT Angiography (CTA) imaging. This platform helps obtain brain perfusion maps and provides fast indication of LVO.
Triage Prioritization Speed
The rapid processing time of Vitrea CT Brain Perfusion (around 3 minutes) directly contributes to faster triage. Canon's Automation Platform, leveraging Vitrea, swiftly analyzes and categorizes brain images, leading to quick availability of images and supporting fast clinical decision-making, particularly beneficial during night-time operations.
ASPECTS Score Automation
Canon's Stroke CT Alberta Stroke Program Early CT Score (CINAu00ae ASPECTS) application, part of the integrated stroke solutions that include Vitrea Advanced Visualization CT Brain Perfusion, utilizes deep learning algorithms to identify potential ischemia and provides an ASPECTS score from non-contrast CT imaging.
Mobile Notification System
Canon's Mobile App for Stroke CT/MR provides automated real-time alerts and notifications, enabling remote viewing of cases, images, and results. This app supports multiple AI applications, including those integrated with Vitrea Advanced Visualization CT Brain Perfusion.
Physician Tip

Vitrea CT Brain Perfusion is a critical tool for acute ischemic stroke assessment, aiding in the quantification of infarct and penumbra volumes to determine endovascular treatment eligibility. It provides comprehensive perfusion maps (CBV, CBF, MTT, TTP, Tmax, delay time) essential for identifying ischemic tissues and evaluating tissue viability. The Bayesian processing method enhances diagnostic confidence, particularly in acute stroke cases, by improving clarity in low signal-to-noise ratio images. The software's ability to visualize apparent blood perfusion helps differentiate between normal and diseased brain tissue.

Vitrea CT Brain Perfusion is a core application within the Vitrea Advanced Visualization platform. It seamlessly integrates with Canon's Automation Platform, which provides AI-based solutions for stroke management, including detection of Large Vessel Occlusion (LVO) and Intracranial Hemorrhage (ICH). Analyzed perfusion maps and related findings can be saved and displayed in PACS, streamlining the clinical workflow. As a multi-modality, vendor-agnostic solution, Vitrea Advanced Visualization can be integrated across various modalities and clinical service lines, including with Canon Aquilion ONE CT scanners for comprehensive stroke evaluations.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Contact for pricing
DeploymentWorkstation, Extend (up to 3 users), Enterprise (scalable thin client, single server for up to 6 concurrent users)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

Vitrea CT Brain Perfusion was cleared by the FDA under K181247 on November 20, 2018, as a radiological image processing system. It is a noninvasive post-processing application designed to evaluate areas of brain perfusion, calculating cerebral blood flow, cerebral blood volume, local bolus timing, and mean transit time from dynamic CT image data.

Integrations
EHR Not specified
Specialties Emergency Medicine, Neurology, Radiology

What the Web Says

Vitrea CT Brain Perfusion is a software application designed to assist physicians in visualizing apparent blood perfusion in brain tissue affected by acute stroke, aiding in the detection of acute cerebral infarcts and the assessment of penumbra and infarct volumes. It offers both 2D and 4D perfusion capabilities, with automated tools for streamlined workflow and quantitative results. Studies have compared Vitrea's accuracy in predicting infarct and penumbra volumes against other software like RAPID and Sphere, with varied results depending on the treatment cohort (intervention vs. conservative).

Overall: Mixed

Strengths

  • Aids in visualizing apparent blood perfusion in acute stroke.
  • Helps determine the presence of acute cerebral infarcts.
  • Assists in assessing penumbra and infarct volumes.
  • Offers streamlined workflow with automated features like curve-fitting, motion correction, and ROI templating.
  • Provides quantitative results for various perfusion parameters (CBF, CBV, MTT, TTP, Tmax).
  • Can be more accurate in penumbra assessment for conservatively treated patients compared to other software.

Limitations

  • May overestimate infarct volume in patients undergoing intervention.
  • All software, including Vitrea, tends to overestimate penumbra.
  • Network infrastructure can be a bottleneck, impacting processing and transfer times, especially in teleradiology settings.
  • CTP predictability of final infarct volume remains moderate across various software packages.
  • Requires careful consideration of acquisition and processing times in stroke workups, particularly in smaller departments.
  • Some physicians on Reddit question the necessity of CTP for every stroke code, especially with newer trials showing benefits of thrombectomy in large core infarcts.

Based on reviews from: Reddit, PubMed, FDA, Canon Medical Systems USA, ResearchGate, Canon Medical Systems Europe, Viz.ai, Canon Medical Systems Canada Limited, MDPI, YouTube

Last updated: 2026-07-20

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Vitrea CT Brain Perfusion

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Encyclopedia.pub
Artificial Intelligence and Machine Learning in Stroke Care
Vitrea CT Brain Perfusion received FDA approval in November 2018 for quantifying cerebral blood flow and predicting final infarct volumes. Studies suggest it outperforms Rapid-CTP in predicting final infarct volumes, using human interpretation of DWI/FLAIR imaging as the gold standard.
2023-06
MDPI (Journal of Clinical Medicine)
Artificial Intelligence and Machine Learning in the Diagnosis and Management of Stroke: A Narrative Review of United States Food and Drug Administration-Approved Technologies
Vitrea CT Brain Perfusion was FDA approved in November 2018 to quantify cerebral blood flow and predict final infarct volumes, with multiple groups finding it outperforms Rapid-CTP in these predictions. This article reviews FDA-approved AI/ML technologies for stroke diagnosis and management.
2023-05
SciOpen
Implications of Artificial Intelligence in Stroke Intervention and Care
Vitrea CT Brain Perfusion is a non-invasive post-processing tool used to assess brain perfusion, calculating cerebral blood volume, flow, and mean transit time from dynamic CT image data. It aids physicians in visualizing apparent blood perfusion in brain tissue affected by acute ischemic stroke.
2025-04
British Journal of Radiology
Artificial intelligence in neuroradiology: a review of Food and Drug Administration-regulated algorithms
Vitrea CT Brain Perfusion, developed by Canon Vital Images, Inc., is an FDA-cleared algorithm (November 20, 2018) for processing CT perfusion data. This review categorizes and summarizes FDA-cleared AI algorithms in neuroradiology, highlighting their functions and performance.
2026-05
Diagnostics (MDPI AG)
Understanding CT Perfusion in Acute Ischemic Stroke: How Algorithms Shape Perfusion Maps
This journal article, published in 2026, discusses how CT perfusion algorithms influence the estimation of ischemic core and hypoperfused tissue in acute ischemic stroke, mentioning Vitrea CT Brain Perfusion in the context of FDA premarket notifications.
2026-12
accessdata.fda.gov (FDA)
Class 2 Device Recall Vitrea
This FDA recall notice details a Class 2 recall for Vitrea CT Brain Perfusion (versions 6.0 and above) due to potential user confusion when viewing brain perfusion scans acquired with wide coverage shuttle acquisition techniques, which could lead to misdiagnosis or treatment delays.
2026-06
BfArM
Urgent Safety Notice for Vitrea CT Brain Perfusion 2D, Vital Images, Inc.
Vital Images, Inc. issued a Field Safety Notice regarding a device limitation of the Vitrea CT Brain Perfusion 2D application (version 6.0 and above) due to potential inaccurate perfusion maps if data is acquired by an unsupported CT scanner.
2013-04
Canon Medical Informatics
Vitreau00ae Advanced Visualization 7.15.8.SU01 Release Notes
These release notes from January 2020 highlight enhancements to Vitrea CT Brain Perfusion, including improvements in processing speed and collage batch resolution.
2020-01

Videos

Product demos, reviews, and walkthroughs for Vitrea CT Brain Perfusion.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

Vitrea CT Brain Perfusion utilizes AI and automation to streamline workflows and enhance diagnostic precision in stroke assessment. It provides automated calculations of quantitative brain perfusion parameters like rCBV, MTT, rCBF, and TTP, and employs Bayesian processing for improved image clarity, even in low signal-to-noise ratio images.
Vitrea Advanced Visualization, which includes CT Brain Perfusion, is a medical diagnostic system with FDA clearance, indicating its regulatory compliance for clinical use. Canon Medical Informatics emphasizes data control and regulatory adherence, and the platform supports deployment in privately managed cloud environments to help maintain data security and HIPAA compliance.
Vitrea CT Brain Perfusion is one of several AI-powered solutions, with alternatives including RAPID, syngo.via, IntelliSpace Portal, and Viz.ai. Studies comparing these platforms show varying accuracy in infarct and penumbra volume estimations, with Vitrea demonstrating comparable or superior performance in certain assessments depending on the clinical context.
Specific pricing for Vitrea CT Brain Perfusion is generally not publicly disclosed, as it is often part of the broader Vitrea Advanced Visualization enterprise platform. However, Canon Medical Informatics aims to provide cost-efficient access and predictable costs, especially when deployed in customer-managed cloud environments.
Limitations include potential variability in calculated core volumes due to differences in processing techniques and thresholds, and the possibility of over- or underestimation of infarct/penumbra compared to follow-up imaging. Physicians should integrate AI results with comprehensive clinical and other imaging data, as factors like patient motion or contrast injection speed can impact AI accuracy.
Vitrea Advanced Visualization is designed for seamless integration with existing systems like EHRs and PACS, optimizing interoperability within healthcare IT environments. While cybersecurity vulnerabilities have been identified in related Vitrea products in the past, Canon Medical has developed patches, underscoring the ongoing need for robust security measures and updates to protect patient information.

Related Tools

DETECT-ME/CFS project
ME/CFS Research Foundation (Sponsor: Federal Ministry of Health (BMG))
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Neurotrack
Neurotrack
Clinical Decision Support & Reference
Neurotrack is a cognitive care enablement platform that provides clinically validated, FDA class II device assessments and care planning support to identify and manage cognitive decline and dementia earlier and with greater accuracy.
LesionQuant
CorTechs Labs
Neurology AI
LesionQuant, an FDA-approved AI product by CorTechs Labs, is particularly useful for patients with multiple sclerosis. It provides brain structure data and quantifies the number, size, and location of lesions, comparing them to prior studies.
ExcelsiusGPS
Globus Medical
Neurology AI
ExcelsiusGPS™ is the first and only robotic navigation platform on the market that offers a comprehensive approach to spine and cranial procedures, from start to finish. The system enables repeatable and accurate trajectory alignment and navigation for placing screws, interbody implants, and cranial instruments.
Onera SleepMap
Onera B.V.
Neurology AI
Onera SleepMap is an AI-powered sleep analysis software that processes polysomnography data, part of Onera Health's innovative patch-based system for at-home and in-lab sleep studies. The system aims to make clinical-grade sleep diagnostics more accessible and user-friendly, providing comprehensive data comparable to traditional in-lab PSG.
JLK-NCCT
JLK-NCCT
Clinical Decision Support & Reference
JLK-NCCT is an AI software designed to assist in the analysis of non-contrast CT brain scans for the detection of acute ischemic stroke.

See all Neurology AI tools →

Suggest an Edit → | Last Verified: 2026-04-19 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.